Targeting Leukemia Initiating Cells by MUC1-C Subunit Inhibition

被引:3
|
作者
Stroopinsky, Dina [1 ]
Rosenblatt, Jacalyn [1 ]
Mills, Heidi [1 ]
Nardella, Caterina [1 ]
Ito, Keisuke [1 ]
Yin, Li [2 ]
Rajabi, Hasan [2 ]
Vasir, Baldev [2 ]
Kufe, Turner [1 ]
Luptakova, Katarina [1 ]
Arnason, Jon E. [1 ]
Levine, James D. [1 ]
Joyce, Robin [1 ]
Tzachanis, Dimitrios [1 ]
Boussiotis, Vassiliki A. [1 ]
Galinsky, Ilene [2 ]
Stone, Richard M. [2 ]
Reiter, Yoram [3 ]
Pandolfi, Pier Paolo [1 ]
Kufe, Donald [2 ]
Avigan, David [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Technion Israel Inst Technol, Haifa, Israel
关键词
D O I
10.1182/blood.V120.21.3583.3583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3583
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein
    C Jin
    H Rajabi
    C M Rodrigo
    J A Porco
    D Kufe
    Oncogene, 2013, 32 : 2179 - 2188
  • [22] MUC1-C drives MYC in multiple myeloma
    Tagde, Ashujit
    Rajabi, Hasan
    Bouillez, Audrey
    Alam, Maroof
    Gali, Reddy
    Bailey, Shannon
    Tai, Yu-Tzu
    Hideshima, Teru
    Anderson, Kenneth
    Avigan, David
    Kufe, Donald
    BLOOD, 2016, 127 (21) : 2587 - 2597
  • [23] MUC1-C: The Occam Razor of Osimertinib Resistance?
    Yalamanchali, Anirudh
    Hassan, Khaled A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (03) : 370 - 372
  • [24] MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells
    Hasan Rajabi
    Tsuyoshi Hata
    Wei Li
    Mark D. Long
    Qiang Hu
    Song Liu
    Deepak Raina
    Ling Kui
    Yota Yasumizu
    Deli Hong
    Mehmet Samur
    Donald Kufe
    Oncogene, 2019, 38 : 7266 - 7277
  • [25] The MUC1-C oncoprotein as a target in hematologic malignancies
    Schlom, Jeffrey
    CANCER BIOLOGY & THERAPY, 2010, 10 (05)
  • [26] Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
    Hiraki, Masayuki
    Maeda, Takahiro
    Mehrotra, Neha
    Jin, Caining
    Alam, Maroof
    Bouillez, Audrey
    Hata, Tsuyoshi
    Tagde, Ashujit
    Keating, Amy
    Kharbanda, Surender
    Singh, Harpal
    Kufe, Donald
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
  • [27] Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
    Xin GongSun
    Zhao, YongQiang
    Jiang, Bin
    Xin, ZhongWei
    Shi, Mo
    Song, Liang
    Qin, QiMing
    Wang, Qiang
    Liu, XiangYan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 12019 - 12028
  • [28] Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
    Raina, D.
    Uchida, Y.
    Kharbanda, A.
    Rajabi, H.
    Panchamoorthy, G.
    Jin, C.
    Kharbanda, S.
    Scaltriti, M.
    Baselga, J.
    Kufe, D.
    ONCOGENE, 2014, 33 (26) : 3422 - 3431
  • [29] Development of novel MUC1-C targeting antibody-drug conjugate for pancreatic cancer treatment
    Ahmad, Rehan
    Panchamoorthy, Govind
    Raina, Deepak
    Lawney, Brian
    Kharbanda, Surender
    Jasuja, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
    D Raina
    Y Uchida
    A Kharbanda
    H Rajabi
    G Panchamoorthy
    C Jin
    S Kharbanda
    M Scaltriti
    J Baselga
    D Kufe
    Oncogene, 2014, 33 : 3422 - 3431